{"id":"https://openalex.org/W2051289613","doi":"https://doi.org/10.1002/pros.1083","title":"Reduction of human prostate tumor vascularity by the \u03b11\u2010adrenoceptor antagonist terazosin","display_name":"Reduction of human prostate tumor vascularity by the \u03b11\u2010adrenoceptor antagonist terazosin","publication_year":2001,"publication_date":"2001-06-26","ids":{"openalex":"https://openalex.org/W2051289613","doi":"https://doi.org/10.1002/pros.1083","mag":"2051289613","pmid":"https://pubmed.ncbi.nlm.nih.gov/11433417"},"language":"en","primary_location":{"id":"doi:10.1002/pros.1083","doi":"https://doi.org/10.1002/pros.1083","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pros.1083","pdf_url":null,"source":{"id":"https://openalex.org/S197000376","display_name":"The Prostate","issn_l":"0270-4137","issn":["0270-4137","1097-0045"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Prostate","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032818590","display_name":"Kaspar M. Keledjian","orcid":"https://orcid.org/0009-0008-5097-1944","observed_orcids":["https://orcid.org/0009-0008-5097-1944"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaspar Keledjian","raw_affiliation_strings":["Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA","Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109320419","display_name":"Andrew Borkowski","orcid":"https://orcid.org/0000-0002-5473-4208","observed_orcids":["https://orcid.org/0000-0002-5473-4208"]},"institutions":[{"id":"https://openalex.org/I4210140381","display_name":"Baltimore VA Medical Center","ror":"https://ror.org/036a0e562","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210111569","https://openalex.org/I4210140381","https://openalex.org/I4210163125"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Borkowski","raw_affiliation_strings":["Department of Pathology, VA Medical Center, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, VA Medical Center, Baltimore, Maryland","institution_ids":["https://openalex.org/I4210140381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113552932","display_name":"Grace Kim","orcid":"https://orcid.org/0009-0003-9597-2151","observed_orcids":["https://orcid.org/0009-0003-9597-2151"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grace Kim","raw_affiliation_strings":["Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043265453","display_name":"John T. Isaacs","orcid":"https://orcid.org/0000-0002-3854-4658","observed_orcids":["https://orcid.org/0000-0002-3854-4658"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John T. Isaacs","raw_affiliation_strings":["The Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112833126","display_name":"Stephen C. Jacobs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen C. Jacobs","raw_affiliation_strings":["Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102885741","display_name":"Natasha Kyprianou","orcid":"https://orcid.org/0000-0002-8713-3599","observed_orcids":["https://orcid.org/0000-0002-8713-3599","https://orcid.org/0000-0002-9382-9664"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Natasha Kyprianou","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland","Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5102885741"],"corresponding_institution_ids":["https://openalex.org/I126744593"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":1.0473,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.74142435,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"48","issue":"2","first_page":"71","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5473999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.5473999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.37130001187324524,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.05570000037550926,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/terazosin","display_name":"terazosin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.7799999713897705},{"id":"https://openalex.org/keywords/tumor-vascularity","display_name":"tumor vascularity","score":0.9110000133514404},{"id":"https://openalex.org/keywords/alpha1-adrenoceptor-antagonists","display_name":"alpha1-adrenoceptor antagonists","score":0.9549999833106995},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6679999828338623},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.8399999737739563},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.8349999785423279},{"id":"https://openalex.org/keywords/quinazoline-derivatives","display_name":"quinazoline derivatives","score":0.7680000066757202},{"id":"https://openalex.org/keywords/doxazosin","display_name":"doxazosin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.609000027179718},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9369999766349792},{"id":"https://openalex.org/keywords/ki67-cell-proliferation","display_name":"Ki-67 cell proliferation","score":0.824999988079071},{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":0.8420000076293945},{"id":"https://openalex.org/keywords/prostate-cancer-treatment","display_name":"prostate cancer treatment","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C2776679619","wikidata":"https://www.wikidata.org/wiki/Q280786","display_name":"Terazosin","level":3,"score":0.9185326099395752},{"id":"https://openalex.org/C2777590997","wikidata":"https://www.wikidata.org/wiki/Q419939","display_name":"Doxazosin","level":3,"score":0.8068264722824097},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7898955941200256},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.698153018951416},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.6380654573440552},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.6179121136665344},{"id":"https://openalex.org/C178596483","wikidata":"https://www.wikidata.org/wiki/Q7916472","display_name":"Vascularity","level":2,"score":0.5553528070449829},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.5025973320007324},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.45208966732025146},{"id":"https://openalex.org/C2776085573","wikidata":"https://www.wikidata.org/wiki/Q7249605","display_name":"Proliferative index","level":3,"score":0.42975255846977234},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.4221600592136383},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3313521146774292},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32821375131607056},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32314395904541016},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.20373570919036865},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.06724521517753601},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008222","descriptor_name":"Lymphokines","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008222","descriptor_name":"Lymphokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016228","descriptor_name":"Endothelial Growth Factors","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016228","descriptor_name":"Endothelial Growth Factors","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D042442","descriptor_name":"Vascular Endothelial Growth Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pros.1083","doi":"https://doi.org/10.1002/pros.1083","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pros.1083","pdf_url":null,"source":{"id":"https://openalex.org/S197000376","display_name":"The Prostate","issn_l":"0270-4137","issn":["0270-4137","1097-0045"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Prostate","raw_type":"journal-article"},{"id":"pmid:11433417","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11433417","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Prostate","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W127182478","https://openalex.org/W127934333","https://openalex.org/W153934429","https://openalex.org/W1486952607","https://openalex.org/W1499584739","https://openalex.org/W1578283200","https://openalex.org/W1886431457","https://openalex.org/W1963776052","https://openalex.org/W1968710139","https://openalex.org/W1970629830","https://openalex.org/W1971353320","https://openalex.org/W1973758764","https://openalex.org/W1974643735","https://openalex.org/W1974940609","https://openalex.org/W1975137665","https://openalex.org/W1976271632","https://openalex.org/W1983072511","https://openalex.org/W1984300833","https://openalex.org/W1985639424","https://openalex.org/W1985804036","https://openalex.org/W1989780564","https://openalex.org/W1995499810","https://openalex.org/W2014604539","https://openalex.org/W2021377019","https://openalex.org/W2031314819","https://openalex.org/W2039138053","https://openalex.org/W2039787319","https://openalex.org/W2054119278","https://openalex.org/W2058712340","https://openalex.org/W2079157591","https://openalex.org/W2082612334","https://openalex.org/W2092902221","https://openalex.org/W2098856542","https://openalex.org/W2117311745","https://openalex.org/W2123927174","https://openalex.org/W2124559417","https://openalex.org/W2130395392","https://openalex.org/W2132156072","https://openalex.org/W2135741249","https://openalex.org/W2324677651","https://openalex.org/W2413616408","https://openalex.org/W2417983633","https://openalex.org/W2474872448","https://openalex.org/W4245635197"],"related_works":["https://openalex.org/W1486952607","https://openalex.org/W2332080456","https://openalex.org/W2006038635","https://openalex.org/W2033425477","https://openalex.org/W2079157591","https://openalex.org/W2369630989","https://openalex.org/W2358004638","https://openalex.org/W2001570340","https://openalex.org/W1640337403","https://openalex.org/W2012753554"],"abstract_inverted_index":{"BACKGROUND:":[0],"We":[1],"previously":[2],"demonstrated":[3],"that":[4,202,244,277],"the":[5,27,37,58,75,155,160,172,176,196,205,210,217,241,274,282],"quinazoline-derived":[6],"a1-adrenoceptor":[7,31],"antagonists":[8,32,263],"doxazosin":[9],"and":[10,88,135,270],"terazosin":[11,55,81,184,226],"suppress":[12],"prostate":[13,65,101,111,136,162,191,250,276,286],"cancer":[14,66,102,163],"growth":[15,131],"via":[16],"apoptosis":[17,116,146],"induction.":[18],"The":[19,91],"aim":[20],"of":[21,30,36,43,77,95,145,175,209,284],"this":[22],"study":[23,254],"was":[24,147,167,221],"to":[25,74,159],"determine":[26],"potential":[28,265],"effect":[29],"on":[33,54],"tumor":[34,178,219,251],"vascularity":[35],"human":[38,275],"prostate.":[39],"METHODS:":[40],"A":[41,142],"total":[42],"34":[44],"men":[45],"with":[46,64,80,195,204,268],"benign":[47],"prostatic":[48,151,218],"hyperplasia":[49],"(BPH)":[50],"who":[51],"have":[52],"been":[53],"treatment":[56,78,283],"(for":[57],"obstructive":[59],"symptoms)":[60],"were":[61,71,113,235],"pathologically":[62],"diagnosed":[63],"following":[67],"surgery.":[68],"These":[69,238],"patients":[70,103],"stratified":[72],"according":[73],"length":[76],"periods":[79],"into":[82],"two":[83],"groups,":[84],"1":[85],"week-6":[86],"months,":[87],"6-17":[89],"months.":[90],"control":[92],"group":[93,198],"consisted":[94],"prostatectomy":[96],"specimens":[97,112],"from":[98],"25":[99],"untreated":[100,161,197],"undergoing":[104],"surgery":[105],"for":[106,115,281],"localized":[107],"disease.":[108],"Formalin-fixed,":[109],"paraffin-embedded":[110],"analyzed":[114],"(TUNEL":[117],"assay),":[118],"cell":[119,179],"proliferation":[120],"(Ki-67),":[121],"microvessel":[122],"density":[123],"(MVD)":[124],"(von":[125],"Willebrand":[126],"factor/Factor":[127],"VIII),":[128],"vascular":[129],"endothelial":[130],"factor":[132],"(VEGF)":[133],"expression,":[134],"specific":[137],"antigen":[138],"(PSA)":[139],"immunoreactivity.":[140],"RESULTS:":[141],"significant":[143,169,188,230,256],"induction":[144],"observed":[148],"among":[149],"cancerous":[150,211],"epithelial":[152],"cells":[153],"in":[154,171,186,190,216,232,259,273],"terazosin-treated,":[156],"as":[157,264],"compared":[158,194],"specimens,":[164],"while":[165,228],"there":[166],"no":[168,229],"change":[170],"proliferative":[173],"index":[174,208],"same":[177],"populations":[180],"after":[181,225],"treatment.":[182],"Furthermore,":[183],"resulted":[185],"a":[187,246],"decrease":[189],"tissue":[192],"MVD":[193],"(P":[199],"<":[200],"0.01),":[201],"correlated":[203],"increased":[206],"apoptotic":[207,269],"areas.":[212],"Tissue":[213],"PSA":[214],"expression":[215,234],"foci":[220],"also":[222],"markedly":[223],"reduced":[224],"treatment,":[227],"changes":[231],"VEGF":[233],"detected.":[236],"CONCLUSIONS:":[237],"findings":[239],"provide":[240],"first":[242],"evidence":[243],"terazosin,":[245],"quinazoline-based":[247],"a1-blocker":[248],"decreases":[249],"vascularity.":[252],"Our":[253],"has":[255],"clinical":[257],"implications":[258],"identifying":[260],"selected":[261],"alpha1-adrenoceptor":[262],"anti-tumor":[266],"agents":[267],"anti-angiogenic":[271],"effects":[272],"can":[278],"be":[279],"exploited":[280],"advanced":[285],"cancer.":[287]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}